General
Preferred name
zuclopenthixol
Synonyms
CLOPENTHIXOL ()
N-746 ()
AY-62021 ()
Chlorpenthixol ()
cis-Clopenthixol ()
Cisordinol ()
(Z)-Clopenthixol ()
Zuclopenthixol hydrochloride ()
Zuclopenthixol dihydrochloride ()
Clopenthixol cis(z)-form ()
Clopixol ()
Zoclopenthixol ()
Zuclopentixol ()
P&D ID
PD009440
CAS
58045-23-1
63978-46-1
53772-83-1
633-59-0
Tags
available
drug
Approved by
MHRA
Drug indication
Psychosis
Schizophrenia
Drug Status
approved
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Zuclopenthixol is a thioxanthene class typical antipsychotic. Chemically it is the cis-isomer of clopenthixol. The CAS registry number (53772-83-1) submitted with the WHO INN record for zuclopenthixol maps to PubChem CID 5311507.
(GtoPdb)
TOXICITY
Although there have not been any cases of overdosage reported, the symptoms are likely to be somnolence, coma, extrapyramidal symptoms, convulsions, hypotension, shock, or hyper- or hypothermia.; ; Neuroleptic malignant syndrome may occur. Zuclopenthixol may potentiate anticholinergic effects of concurrent medications. Zuclopenthixol has a demonstrated antiemetic effect in animals, and may mask signs of toxicity due to other drug overdoses, or may mask symptoms of disease.
PRICE
29
DESCRIPTION
Zuclopenthixol is an antagonist at D1 and D2 dopamine receptors. It also has high affinity for alpha1-adrenergic and 5-HT2 receptors, but it has weaker histamine H1 receptor blocking activity, and even lower affinity for muscarinic cholinergic and alpha2-adrenergic receptors. lt is the cis-isomer of clopenthixol. It is an antipsychotic drug belonging the thioxanthene class. It was introduced in 1962 by Lundbeck. It has been listed, but is not approved for use in the United States.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Zuclopenthixol (cis-Clopenthixol) is a thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
BOC Sciences Bioactive Compounds
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
Other bioactive compounds
Prestwick Chemical Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
59
Molecular Weight
400.14
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
5
Ring Count
4
Aromatic Ring Count
2
cLogP
4.24
TPSA
26.71
Fraction CSP3
0.36
Chiral centers
0.0
Largest ring
6.0
QED
0.69
Structural alerts
1
styrene_B(8)
c:1:c:c-2:c(:c:c:1)-[#6](-c:3:c(-[$([#16;X2]),$([#6;X4])]-2):c:c:[c;!H0,$(c-[#17]),$(c-[#6;X4])](:c:3))=[#6]-[#6]
PAINS Family C
Custom attributes
(extracted from source data)
Target
D1
D2
dopamine
ADRA1A, ADRA2A, DRD1, DRD2, DRD5, HRH1, HTR2A
Indication
schizophrenia, bipolar disorder
MOA
Dopamine Receptor antagonist
Therapeutic Class
Antipsychotic Agents
Pathway
GPCR/G protein
Neuroscience
Solubility
Benzene, Chloroform, DMSO, Ethanol, Methanol
Source data

